Presenter: Dr. Michael Allan James McCormack BSc (Pharm) Pharm D
0:00
In episode 480, James and Mike talk about two recent meta-analyses that have done a solid job of looking at the impact of lowering blood pressure and using SGLT-2s and GLP-1s to reduce risk. Both publications lend credence to the concept of focusing much more on risk reduction goals than blood pressure or glucose thresholds….
Latest Podcasts
FM Rounds #20: Accompagner les personnes trans et non binaires en médecine familiale
Le groupe d'intérêt des membres sur la santé des patients 2SLGBTQ+ a collaboré avec projet NUANCES, centre de soins en diversité sexuelle et de genre. Dre Judith Lajeunesse et Caroline…
FM Rounds #19: Coming Home: Post-op Gender Affirming Surgery in Primary Care
This podcast discusses two of the most common gender-affirming surgeries - vaginoplasty in a transfeminine patient and top surgery or mastectomy in a trans masculine patient. These are emotionally high…
BS Medicine Episode #623: Less than 140, 130, or 120? Counting down to the optimal systolic blood pressure target
In episode 623, Jamie and James invite Samantha Moe back again to talk about the never-ending debate as to what is the target for systolic blood pressure. We look at…
November 12, 2021
Presenter(s):
Dr. Michael Allan James McCormack BSc (Pharm) Pharm D
Please provide any additional comments (optional).